UBS Group’s Exelixis EXEL Stock Holding History

UBS Group’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-45,400	Closed	-$1.02M	–	9642
2024 Q2	$1.02M	Buy	+45,400	New	+$1.01M	﹤0.01%	4409
2024 Q1	–	Sell	-49,900	Closed	-$1.2M	–	9491
2023 Q4	$1.2M	Hold	49,900	–	–	﹤0.01%	4340
2023 Q3	$1.09M	Sell	49,900 -53,300	-52%	-$1.11M	﹤0.01%	3992
2023 Q2	$1.97M	Buy	103,200 +26,600	+35%	+$513K	﹤0.01%	3540
2023 Q1	$1.49M	Buy	+76,600	New	+$1.33M	﹤0.01%	3731
2017 Q2	–	Sell	-1,602,400	Closed	-$34.7M	–	7754
2017 Q1	$34.7M	Buy	1,602,400 +1,102,400	+220%	+$22.4M	0.02%	710
2016 Q4	$7.46M	Buy	+500,000	New	+$7.21M	﹤0.01%	1743
2015 Q2	–	Sell	-58,100	Closed	-$149K	–	8586
2015 Q1	$149K	Sell	58,100 -17,200	-23%	-$39.9K	﹤0.01%	5116
2014 Q4	$108K	Buy	+75,300	New	+$117K	﹤0.01%	5626

Other funds holding EXEL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group's EXEL Position: Q2 2026 in Review

UBS Group increased its Exelixis (EXEL) stake by 32% in Q2 2026, buying an estimated $37.7M and bringing the position to 3,167,890 shares worth $172M. The position accounts for 0.02% of the portfolio, ranked #752.

UBS Group first reported a position in EXEL in Q4 2014 and has held it in 47 quarters since. 760 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

UBS Group held 3,167,890 shares of Exelixis worth $172M as of Q2 2026.
UBS Group bought 774,377 Exelixis shares in Q2 2026, an estimated $37.7M.
Exelixis made up 0.02% of UBS Group's portfolio in Q2 2026, its #752 holding.
UBS Group first reported a position in Exelixis in Q4 2014 and has held it in 47 quarters since.
760 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.